Prices delayed by at least 15 minutes | Print


Gsk PLC (GSK)

ORD 31 1/4P
Sell: 1660.8p|Buy: 1661.4p|Change: 11.20 (0.68%)

Open 

1656.4p


Previous close 

1649.6p


Trade high 

1663.6p


Volume 

9,509,166


Year high 

1,719.80p


Year low 

1,302.60p


Dividend yield 

3.52%


Market capitalisation 

£67.40 bn


P/E ratio 

13.76


ISIN 

GB00BN7SWP63


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment

Share price

Dividends

PreviousLatest
Record date17/11/202323/02/2024
Ex-dividend date16/11/202322/02/2024
Payment date11/01/202411/04/2024
Amount14.00p16.00p

Performance 18/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Gsk PLC+ 0.68
FTSE 100- 0.06
More...

Company profile

In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
18/03/202405:42:091647.93196029,920.55
18/03/202405:42:081648.01185078,355.42
18/03/202405:42:081648.029791014,997.07
18/03/202405:42:081648.02195499,047.64
18/03/202405:27:461648.413370711,654.28

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.